Paper32550997
Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors.
Cescon E and 8 others. ACS Med Chem Lett, 2020. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors. Papers, record 32550997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32550997
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11161704 | Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization. | Exp Cell Res | 2001 | https://conductscience.org/library/papers/11161704 | PubMed |
| 2 | 29630366 | Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε. | J Med Chem | 2018 | https://conductscience.org/library/papers/29630366 | PubMed |
| 3 | 19125657 | Empirical scoring functions for advanced protein-ligand docking with PLANTS. | J Chem Inf Model | 2009 | https://conductscience.org/library/papers/19125657 | PubMed |
| 4 | 9126849 | Development and validation of a genetic algorithm for flexible docking. | J Mol Biol | 1997 | https://conductscience.org/library/papers/9126849 | PubMed |
| 5 | 18574471 | CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. | Oncogene | 2008 | https://conductscience.org/library/papers/18574471 | PubMed |
| 6 | 24904820 | The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis. | Front Oncol | 2014 | https://conductscience.org/library/papers/24904820 | PubMed |
| 7 | 22235331 | Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo. | PLoS One | 2012 | https://conductscience.org/library/papers/22235331 | PubMed |
| 8 | 23351099 | Consensus docking: improving the reliability of docking in a virtual screening context. | J Chem Inf Model | 2013 | https://conductscience.org/library/papers/23351099 | PubMed |
| 9 | 20577972 | Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. | Med Res Rev | 2011 | https://conductscience.org/library/papers/20577972 | PubMed |
| 10 | 23861943 | CK1δ kinase activity is modulated by Chk1-mediated phosphorylation. | PLoS One | 2013 | https://conductscience.org/library/papers/23861943 | PubMed |
| 11 | 23919824 | Ligand-protein interactions of selective casein kinase 1δ inhibitors. | J Med Chem | 2013 | https://conductscience.org/library/papers/23919824 | PubMed |
| 12 | 14761950 | Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14761950 | PubMed |
| 13 | 10924763 | Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. | Neurobiol Aging | 2000 | https://conductscience.org/library/papers/10924763 | PubMed |
| 14 | 31376410 | Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D). | Gene | 2019 | https://conductscience.org/library/papers/31376410 | PubMed |
| 15 | 15722192 | The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. | Cell Signal | 2005 | https://conductscience.org/library/papers/15722192 | PubMed |
| 16 | 28609096 | Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors. | ACS Chem Neurosci | 2017 | https://conductscience.org/library/papers/28609096 | PubMed |
| 17 | 24592867 | Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. | J Med Chem | 2014 | https://conductscience.org/library/papers/24592867 | PubMed |
| 18 | 26769969 | Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26769969 | PubMed |
| 19 | 26035098 | DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations. | Molecules | 2015 | https://conductscience.org/library/papers/26035098 | PubMed |
| 20 | 7665585 | Role of COOH-terminal phosphorylation in the regulation of casein kinase I delta. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7665585 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39174535 | Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39174535 | PubMed |
| 39073853 | Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. | J Med Chem | 2024 | https://conductscience.org/library/papers/39073853 | PubMed |
| 38931832 | Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now? | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38931832 | PubMed |
| 37259317 | "Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37259317 | PubMed |
| 36315402 | Qualitative Estimation of Protein-Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations. | J Chem Inf Model | 2022 | https://conductscience.org/library/papers/36315402 | PubMed |
| 35874609 | Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35874609 | PubMed |
| 33324805 | Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors. | ACS Omega | 2020 | https://conductscience.org/library/papers/33324805 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CSNK1D | 1453 | PubTator's text mining | https://conductscience.org/library/genes/1453 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32550997
GET https://conductscience.org/api/papers/v1/32550997/references?page=2